Danielle J Ingle1,2, Marion Easton3, Mary Valcanis1, Torsten Seemann1,4,5, Jason C Kwong5, Nicola Stephens3, Glen P Carter1,5, Anders Gonçalves da Silva1, James Adamopoulos3, Sarah L Baines5, Kathryn E Holt6,7, Eric P F Chow8,9, Christopher K Fairley8,9, Marcus Y Chen8,9, Martyn D Kirk2, Benjamin P Howden1,5, Deborah A Williamson1,5. 1. Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne. 2. National Centre for Epidemiology and Population Health, The Australian National University, Canberra. 3. Victorian Department of Health and Human Services, Melbourne. 4. Melbourne Bioinformatics Group, Victoria, Australia. 5. Doherty Applied Microbial Genomics, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Parkville, Australia. 6. Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Australia. 7. London School of Hygiene and Tropical Medicine, United Kingdom. 8. Melbourne Sexual Health Centre, Alfred Health, Carlton. 9. Central Clinical School, Monash University, Melbourne, Australia.
Abstract
BACKGROUND: In urban Australia, the burden of shigellosis is either in returning travelers from shigellosis-endemic regions or in men who have sex with men (MSM). Here, we combine genomic data with comprehensive epidemiological data on sexual exposure and travel to describe the spread of multidrug-resistant Shigella lineages. METHODS: A population-level study of all cultured Shigella isolates in the state of Victoria, Australia, was undertaken from 1 January 2016 through 31 March 2018. Antimicrobial susceptibility testing, whole-genome sequencing, and bioinformatic analyses of 545 Shigella isolates were performed at the Microbiological Diagnostic Unit Public Health Laboratory. Risk factor data on travel and sexual exposure were collected through enhanced surveillance forms or by interviews. RESULTS: Rates of antimicrobial resistance were high, with 17.6% (95/541) and 50.6% (274/541) resistance to ciprofloxacin and azithromycin, respectively. There were strong associations between antimicrobial resistance, phylogeny, and epidemiology. Specifically, 2 major MSM-associated lineages were identified: a Shigellasonnei lineage (n = 159) and a Shigella flexneri 2a lineage (n = 105). Of concern, 147/159 (92.4%) of isolates within the S. sonnei MSM-associated lineage harbored mutations associated with reduced susceptibility to recommended oral antimicrobials: namely, azithromycin, trimethoprim-sulfamethoxazole, and ciprofloxacin. Long-read sequencing demonstrated global dissemination of multidrug-resistant plasmids across Shigella species and lineages, but predominantly associated with MSM isolates. CONCLUSIONS: Our contemporary data highlight the ongoing public health threat posed by resistant Shigella, both in Australia and globally. Urgent multidisciplinary public health measures are required to interrupt transmission and prevent infection.
BACKGROUND: In urban Australia, the burden of shigellosis is either in returning travelers from shigellosis-endemic regions or in men who have sex with men (MSM). Here, we combine genomic data with comprehensive epidemiological data on sexual exposure and travel to describe the spread of multidrug-resistant Shigella lineages. METHODS: A population-level study of all cultured Shigella isolates in the state of Victoria, Australia, was undertaken from 1 January 2016 through 31 March 2018. Antimicrobial susceptibility testing, whole-genome sequencing, and bioinformatic analyses of 545 Shigella isolates were performed at the Microbiological Diagnostic Unit Public Health Laboratory. Risk factor data on travel and sexual exposure were collected through enhanced surveillance forms or by interviews. RESULTS: Rates of antimicrobial resistance were high, with 17.6% (95/541) and 50.6% (274/541) resistance to ciprofloxacin and azithromycin, respectively. There were strong associations between antimicrobial resistance, phylogeny, and epidemiology. Specifically, 2 major MSM-associated lineages were identified: a Shigellasonnei lineage (n = 159) and a Shigella flexneri 2a lineage (n = 105). Of concern, 147/159 (92.4%) of isolates within the S. sonnei MSM-associated lineage harbored mutations associated with reduced susceptibility to recommended oral antimicrobials: namely, azithromycin, trimethoprim-sulfamethoxazole, and ciprofloxacin. Long-read sequencing demonstrated global dissemination of multidrug-resistant plasmids across Shigella species and lineages, but predominantly associated with MSM isolates. CONCLUSIONS: Our contemporary data highlight the ongoing public health threat posed by resistant Shigella, both in Australia and globally. Urgent multidisciplinary public health measures are required to interrupt transmission and prevent infection.
Authors: Edgar I Campos-Madueno; Odette J Bernasconi; Aline I Moser; Peter M Keller; Francesco Luzzaro; Carola Maffioli; Thomas Bodmer; Andreas Kronenberg; Andrea Endimiani Journal: Antimicrob Agents Chemother Date: 2020-09-21 Impact factor: 5.191
Authors: Lawrence Purpura; Jason Zucker; Elijah LaSota; Mabel Lopez; Rebecca Spicehandler; Caroline Carnevale; Edward Perez; Paul Richards; Jennifer Chang; Al Cohall; Anne-Catrin Uhlemann; Susan Whittier; Magdalena E Sobieszczyk; Daniel A Green Journal: Open Forum Infect Dis Date: 2021-08-03 Impact factor: 4.423
Authors: P Malaka De Silva; George E Stenhouse; Grace A Blackwell; Rebecca J Bengtsson; Claire Jenkins; James P J Hall; Kate S Baker Journal: Proc Biol Sci Date: 2022-08-03 Impact factor: 5.530
Authors: Jane Hawkey; Kalani Paranagama; Kate S Baker; Rebecca J Bengtsson; François-Xavier Weill; Nicholas R Thomson; Stephen Baker; Louise Cerdeira; Zamin Iqbal; Martin Hunt; Danielle J Ingle; Timothy J Dallman; Claire Jenkins; Deborah A Williamson; Kathryn E Holt Journal: Nat Commun Date: 2021-05-11 Impact factor: 14.919
Authors: George E Stenhouse; Khuzwayo C Jere; Chikondi Peno; Rebecca J Bengtsson; End Chinyama; Jonathan Mandolo; Amy Cain; Miren Iturriza-Gómara; Naor Bar-Zeev; Nigel A Cunliffe; Jennifer Cornick; Kate S Baker Journal: Microb Genom Date: 2021-05